Mode
Text Size
Log in / Sign up

Latent Tuberculosis Infection

Part of Tuberculosis

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Latent Tuberculosis Infection

5 trials tracked for Latent Tuberculosis Infection: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 176 citations.

5Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 1 1 Other / NA 3
  1. Phase 3 Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT Completed · 176 cited
  2. Phase 1 Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy Volunteers Completed
  3. N/A Screening for Latent Tuberculosis Infection (LTBI) in US Army Recruits Completed
  4. N/A Nurse-Led Community Health Worker Adherence Model in 3HP Delivery Among Homeless Adults at Risk for TB Infection and HIV Completed
  5. N/A Diagnosis of Tuberculosis Infection in Health Care Workers Using Ex-vivo Interferon-gamma Assay Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found For clinicians

Latent Tuberculosis Infection: what the trials found

In a Phase 3 trial of isoniazid and rifapentine for latent tuberculosis infection, the treatment was evaluated in terms of completion rates and safety. The study observed varying counts of participants completing treatment across different groups (294, 271, 266, 294, 248, and 249).

Safety data for the isoniazid and rifapentine regimen showed a total of 23, 23, and 29 instances of drug-related Grade 3 or 4 adverse events or death across the study groups. Reasons for failure to complete treatment were also documented with counts of 3, 7, 4, 12, 18, and 14 respectively.

Recent results — preliminary, needs further review

  • RUTI was evaluated in a Phase 1 trial (not yet corroborated).
  • A Nurse-led Community Health Worker TBI (RN/CHW TBI) program showed no statistically significant differences in drug use (p=0.603), alcohol use (p=0.672), or depression (p=0.719).
  • BST was evaluated in a study involving 2,017 participants (not yet corroborated).
  • A 1-step tuberculin skin test (TST) and blood sampling were utilized in a study of 322 participants (not yet corroborated).

For the clinician treating this condition

  • Isoniazid and rifapentine are established interventions for latent tuberculosis infection, with documented completion rates and safety profiles regarding Grade 3 or 4 adverse events.
  • Clinical data on the specific impact of nurse-led community health worker programs on substance use and depression in TBI patients is currently not corroborated.

AI synthesis of 0 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Tuberculosis

Related studies from across the Tuberculosis family.

Risk prediction models for anti-tuberculosis drug-induced liver injury show pooled AUC of 0.81
Primary Care & Family Medicine Meta-analysis
Risk prediction models for anti-tuberculosis drug-induced liver injury show pooled AUC of 0.81 Risk Prediction Models Help Identify Liver Damage from Tuberculosis Drugs
This meta-analysis of 26 studies involving 41,734 cases evaluated risk prediction models for anti-tuberculosis drug-induced liver injury (AT…
New risk models can help identify patients at risk for liver injury when taking tuberculosis medications, especially those with specific hea…
Sensititre MYCOTB shows high diagnostic accuracy for rifampicin and isoniazid in tuberculosis isolates
Infectious Disease Meta-analysis
Sensititre MYCOTB shows high diagnostic accuracy for rifampicin and isoniazid in tuberculosis isolates New test shows high accuracy for detecting drug resistant tuberculosis
This meta-analysis of 1,728 isolates evaluates the diagnostic performance of Sensititre MYCOTB against reference drug susceptibility testing…
A new testing method shows high accuracy in identifying which drugs can successfully treat drug-resistant tuberculosis infections.
Bronchoscopic resection and individualized therapy may treat tracheobronchial tuberculosis presenting as endobronchial masses
Rheumatology Sys. Review
Bronchoscopic resection and individualized therapy may treat tracheobronchial tuberculosis presenting as endobronchial masses Rare airway tuberculosis found in young man's bronchial mass
This case report and literature review describes a 21-year-old male with tumorous tracheobronchial tuberculosis complicated by infiltrative …
A 21-year-old's airway mass turned out to be a rare form of tuberculosis. Early removal and treatment led to marked improvement.
Expanded TB Screening in HIV Inpatients Shows No Benefit
Infectious Disease RCT
Expanded TB Screening in HIV Inpatients Shows No Benefit Expanded Screening Does Not Speed Tuberculosis Treatment for HIV Patients
In HIV-positive hospital inpatients, expanded TB screening with Xpert Ultra and LF-LAM did not improve treatment initiation or 8-week mortal…
A large trial in Tanzania and Mozambique found that expanded screening did not speed up tuberculosis treatment or reduce deaths for patients…
Tuberculosis prevalence among children with severe acute malnutrition is 13% (95% CI: 11-16%)
Infectious Disease Meta-analysis
Tuberculosis prevalence among children with severe acute malnutrition is 13% (95% CI: 11-16%) Tuberculosis is common among children with severe acute malnutrition
This meta-analysis of 33,869 children across 15 countries identifies a pooled tuberculosis prevalence of 13% in those with severe acute maln…
Over 13% of children suffering from severe acute malnutrition also have tuberculosis, highlighting a critical need for integrated screening.
WGS-based tools provide high specificity and sensitivity for rifampicin, isoniazid, and fluoroquinolone resistance detection
Infectious Disease Meta-analysis
WGS-based tools provide high specificity and sensitivity for rifampicin, isoniazid, and fluoroquinolone resistance detection New tools help doctors identify drug resistant tuberculosis strains
This meta-analysis of 144,623 M. tuberculosis genomes evaluates six open-access WGS-based drug susceptibility testing prediction tools. The …
New computer tools can accurately predict if common drugs will work against tuberculosis, helping doctors choose the right treatment faster.
Pulmonary TB History Linked to Higher COPD Odds
Rheumatology Meta-analysis
Pulmonary TB History Linked to Higher COPD Odds Past tuberculosis infection significantly increases risk of developing lung disease
Meta-analysis of over 1 million people finds prior pulmonary TB associated with 2.65 times higher odds of COPD.
A history of pulmonary tuberculosis is linked to a much higher risk of developing chronic obstructive pulmonary disease, especially in certa…
TB-TST mobile application increases treatment success to 82% in drug susceptible tuberculosis
Infectious Disease RCT
TB-TST mobile application increases treatment success to 82% in drug susceptible tuberculosis Mobile App Improves Success Rates for Tuberculosis Treatment
This pragmatic randomized controlled trial of 555 individuals with newly diagnosed drug susceptible tuberculosis found that the TB-TST inter…
A mobile app and urine tests helped more patients complete their tuberculosis treatment compared to standard care alone.
Modified regimens for drug-resistant tuberculosis show higher success rates than standard regimens in Cameroon
Infectious Disease Meta-analysis
Modified regimens for drug-resistant tuberculosis show higher success rates than standard regimens in Cameroon Modified drug regimens show higher success for drug-resistant tuberculosis
This systematic review and meta-analysis of 2,351 patients with drug-resistant tuberculosis (DR-TB) in Cameroon found that modified regimens…
A new analysis shows modified treatment plans can improve success rates for patients fighting drug-resistant tuberculosis.
Baseline auramine count predicts tuberculosis failure or relapse by 5% higher odds per 100 bacilli
Infectious Disease RCT
Baseline auramine count predicts tuberculosis failure or relapse by 5% higher odds per 100 bacilli Auramine Levels May Predict Treatment Success for Tuberculosis Patients
This secondary analysis of an RCT involving 321 patients treated with double-dose R. found that quantitative baseline auramine significantly…
A study suggests that specific bacteria counts at the start of treatment can help predict if a patient with tuberculosis will experience a r…
HIV co-infection triples MDR-TB mortality risk; low BMI and anaemia also raise risk
Infectious Disease Meta-analysis
HIV co-infection triples MDR-TB mortality risk; low BMI and anaemia also raise risk HIV and other risk factors linked to multidrug-resistant tuberculosis deaths
This meta-analysis of 36,693 patients with multidrug-resistant tuberculosis (MDR-TB) found that HIV co-infection, lower educational attainme…
Patients with multidrug-resistant tuberculosis face higher risks of death if they also have HIV, low body mass index, or certain other healt…
Rifapentine 15 mg/kg and 20 mg/kg yield higher culture conversion than standard 6-month regimen
Infectious Disease RCT
Rifapentine 15 mg/kg and 20 mg/kg yield higher culture conversion than standard 6-month regimen Trial Shows Rifapentine Dosage Impacts Tuberculosis Treatment Outcomes
This Phase 2/3 Stage 1 randomized controlled trial of 400 adults with pulmonary drug-susceptible tuberculosis compared three 4-month rifapen…
A new clinical trial explores how different doses of rifapentine affect treatment success and safety for patients with drug-susceptible tube…